Cargando…

Urolithin A as a Potential Drug for the Treatment of Spinal Cord Injuries: A Mechanistic Study Using Network Pharmacology Approaches

OBJECTIVE: This research was focused to examine the potential targets, action network, and mechanism of urolithin A (UA) in spinal cord injury (SCI) management exploiting the network pharmacology (NP). METHODS: We used the SwissTargetPrediction, PharmMapper, and TargetNet databases to obtain UA acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Chao, Luan, HaoPeng, Gao, ShuTao, Sheng, WeiBin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054438/ https://www.ncbi.nlm.nih.gov/pubmed/35497925 http://dx.doi.org/10.1155/2022/9090113

Ejemplares similares

Telomerase expression in the glial scar of rats with spinal cord injury★
por: Yang, Mingkun, et al.
Publicado: (2012)

Multifocal Noncontiguous Spinal Tuberculosis
por: Gao, Shutao, et al.
Publicado: (2023)

Quercetin Derivatives in Combating Spinal Cord Injury: A Mechanistic and Systematic Review
por: Fakhri, Sajad, et al.
Publicado: (2022)

Acute spinal cord injury: Pathophysiology and pharmacological intervention
por: Zhang, Yi, et al.
Publicado: (2021)

Urolithin A Protects Chondrocytes From Mechanical Overloading-Induced Injuries
por: He, Yuchen, et al.
Publicado: (2021)

Pharmacological Effects of Urolithin A and Its Role in Muscle Health and Performance: Current Knowledge and Prospects
por: Zhao, Haotian, et al.
Publicado: (2023)

Ionic Plasticity: Common Mechanistic Underpinnings of Pathology in Spinal Cord Injury and the Brain
por: Hudson, Kelsey E., et al.
Publicado: (2022)

NMR Spectroscopic Identification of Urolithin G, a Novel Trihydroxy Urolithin Produced by Human Intestinal Enterocloster Species
por: Beltrán, David, et al.
Publicado: (2023)

The mechanisms of Chuanxiong Rhizoma in treating spinal cord injury based on network pharmacology and experimental verification
por: Tao, Bo, et al.
Publicado: (2021)

An Overview of Pharmacological Approaches for Management and Repair of Spinal Cord Injuries
por: Khoshnevisan, Alireza, et al.
Publicado: (2010)

Pharmacologic and Acute Management of Spinal Cord Injury in Adults and Children
por: Thomas, Ajay X., et al.
Publicado: (2022)

Immunomodulatory Role of Urolithin A on Metabolic Diseases
por: Toney, Ashley Mulcahy, et al.
Publicado: (2021)

Potential of Urolithin A to improve joint health
por: D’Amico, Davide, et al.
Publicado: (2023)

Urolithin and Reduced Urolithin Derivatives as Potent Inhibitors of Tyrosinase and Melanogenesis: Importance of the 4-Substituted Resorcinol Moiety
por: Lee, Sanggwon, et al.
Publicado: (2021)

Pharmacological and non-pharmacological therapeutic interventions for the treatment of spinal cord injury-induced pain
por: Eller, Olivia C., et al.
Publicado: (2022)

Importance of brain alterations in spinal cord injury
por: Zhao, Can, et al.
Publicado: (2021)

Pharmacological interventions targeting the microcirculation following traumatic spinal cord injury
por: Wang, Rongrong, et al.
Publicado: (2023)

Chondroitinase ABC plus bone marrow mesenchymal stem cells for repair of spinal cord injury☆
por: Zhang, Chun, et al.
Publicado: (2013)

Deciphering Pharmacological Mechanism of Buyang Huanwu Decoction for Spinal Cord Injury by Network Pharmacology Approach
por: Xiong, Zhencheng, et al.
Publicado: (2021)

Urolithins: A Prospective Alternative against Brain Aging
por: An, Lei, et al.
Publicado: (2023)

Urolithin A alleviates neuropathic pain and activates mitophagy
por: Wang, Chenyi, et al.
Publicado: (2023)

Relationship between Spinal Cord Volume and Spinal Cord Injury due to Spinal Shortening
por: Qiu, Feng, et al.
Publicado: (2015)

Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury
por: Li, Shaoshuo, et al.
Publicado: (2022)

Spinal cord stimulation for spinal cord injury patients with paralysis: To regain walking and dignity
por: Tsai, Sheng-Tzung, et al.
Publicado: (2020)

Effects of ginsenoside Rb1 on spinal cord ischemia-reperfusion injury in rats
por: Ye, Jin-tao, et al.
Publicado: (2019)

Gal-3 is a potential biomarker for spinal cord injury and Gal-3 deficiency attenuates neuroinflammation through ROS/TXNIP/NLRP3 signaling pathway
por: Ren, Zhouliang, et al.
Publicado: (2019)

Role of regulatory T cells in spinal cord injury
por: Chen, Hao, et al.
Publicado: (2023)

In Silico and In Vitro Study of Antioxidant Potential of Urolithins
por: Marchese, Emanuela, et al.
Publicado: (2023)

Urolithin A Promotes Angiogenesis and Tissue Regeneration in a Full-Thickness Cutaneous Wound Model
por: Feng, Zhen-hua, et al.
Publicado: (2022)

Pharmacologic approaches to prevent skeletal muscle atrophy after spinal cord injury
por: Otzel, Dana M., et al.
Publicado: (2021)

Genetic and Probiotic Characteristics of Urolithin A Producing Enterococcus faecium FUA027
por: Xia, Mengjie, et al.
Publicado: (2023)

Antihyperuricemic Effect of Urolithin A in Cultured Hepatocytes and Model Mice
por: Adachi, Shin-ichi, et al.
Publicado: (2020)

Anti-Aging Effect of Urolithin A on Bovine Oocytes In Vitro
por: Fonseca, Élisa, et al.
Publicado: (2021)

Urolithin A attenuates auditory cell senescence by activating mitophagy
por: Cho, Sung Il, et al.
Publicado: (2022)

Study on the biological mechanism of urolithin a on nasopharyngeal carcinoma in vitro
por: Yang, Yang, et al.
Publicado: (2022)

Urolithin A in Health and Diseases: Prospects for Parkinson’s Disease Management
por: Wojciechowska, Olga, et al.
Publicado: (2023)

Pharmacological management of acute spinal cord injury: a longitudinal multi-cohort observational study
por: Jutzeler, Catherine R., et al.
Publicado: (2023)

Multifunctional biomimetic spinal cord: New approach to repair spinal cord injuries
por: Liu, Yang, et al.
Publicado: (2017)

Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain
por: Hama, Aldric T, et al.
Publicado: (2014)

Systematically Investigating the Pharmacological Mechanism of Momordica grosvenori in the Treatment of Spinal Cord Injury by Network Pharmacology and Experimental Verification
por: Wang, Jiling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vg0n5v55empnjipuuhprrcle5k